Bulletin
Investor Alert

New York Markets Open in:

Gamida Cell Ltd.

NAS: GMDA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 17, 2022, 7:56 p.m.

/zigman2/quotes/207657083/composite

$

3.24

Change

-0.04 -1.22%

Volume

Volume 4,492

Quotes are delayed by 20 min

/zigman2/quotes/207657083/composite

Previous close

$ 3.23

$ 3.28

Change

+0.05 +1.55%

Day low

Day high

$3.21

$3.43

Open

52 week low

52 week high

$1.48

$4.96

Open

Company Description

Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm offers Omidubicel, an investigational product with potential as a life-saving alternative for patients in need of a bone marrow transplant, and a line of modified and un...

Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm offers Omidubicel, an investigational product with potential as a life-saving alternative for patients in need of a bone marrow transplant, and a line of modified and unmodified nicotinamide-enabled natural killer cells targeted at solid tumor and hematological malignancies. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Boston, MA.

Valuation

Price to Book Ratio

3.47

Enterprise Value to EBITDA

-2.05

Efficiency

Liquidity

Current Ratio

3.88

Quick Ratio

3.88

Cash Ratio

3.77

Profitability

Return on Assets

-59.02

Return on Equity

-125.87

Return on Total Capital

-75.70

Capital Structure

Total Debt to Total Assets

53.58

Officers and Executives

Name Age Officer Since Title
Mr. Robert I. Blum 57 2018 Chairman
Dr. Julian Adams 66 2016 Chief Executive Officer & Director
Mr. Michele I. Korfin 50 2020 Chief Operating & Commercial Officer
Mr. Shai Lankry 44 2018 Chief Financial Officer
Dr. Yona Geffen - 2020 Vice President-Research & Development

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/09/2022 Ivan M. Borrello
Director
4,000   Award at $0 per share. 0
01/28/2022 Michele I. Korfin
COO/Chief Commercial Officer
63,800   Award at $0 per share. 0
01/28/2022 Shai Lankry
Chief Financial Officer
43,000   Award at $0 per share. 0
01/28/2022 Joshua F. Patterson
General Counsel
51,000   Award at $0 per share. 0
01/28/2022 Anat Cohen-Dayag
Director
4,000   Award at $0 per share. 0
01/27/2022 Naama Halevi-Davidov
Director
4,000   Award at $0 per share. 0
/news/latest/company/us/gmda

MarketWatch News on GMDA

  1. Gamida Cell started at buy with $11 stock price target at Alliance Global

    7:08 a.m. Nov. 1, 2021

    - Tomi Kilgore

  2. Gamida Cell started at outperform with $15 stock price target at Oppenheimer

    8:26 a.m. Nov. 21, 2018

    - Tomi Kilgore

/news/nonmarketwatch/company/us/gmda

Other News on GMDA

  1. Gamida Cell: Gearing Up For FDA Approval

    10:12 a.m. Aug. 16, 2022

    - Seeking Alpha

  2. Gamida Cell Ltd. (GMDA) Q2 2022 Earnings Call Transcript

    3:00 p.m. Aug. 15, 2022

    - Motley Fool

  3. 10-Q: GAMIDA CELL LTD.

    7:37 a.m. Aug. 15, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Gamida Cell GAAP EPS of -$0.31 misses by $0.02

    7:07 a.m. Aug. 15, 2022

    - Seeking Alpha

  5. Notable earnings before Monday's open

    10:53 a.m. Aug. 12, 2022

    - Seeking Alpha

  6. AEMD,GMDA and QNRX are among pre market gainers movers

    8:30 a.m. Aug. 2, 2022

    - Seeking Alpha

  7. Gamida Cell (GMDA) Investor Presentation- Slideshow

    2:24 p.m. June 24, 2022

    - Seeking Alpha

  8. IMMX, ZY and SCOR among premarket gainers

    8:23 a.m. June 2, 2022

    - Seeking Alpha

  9. Gamida Cell (GMDA) Investor Presentation - Slideshow

    2:56 p.m. May 24, 2022

    - Seeking Alpha

  10. 10-Q: GAMIDA CELL LTD.

    7:44 a.m. May 12, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  11. Gamida Cell Ltd. (GMDA) Q1 2022 Earnings Call Transcript

    1:00 p.m. May 10, 2022

    - Motley Fool

  12. Gamida Cell GAAP EPS of -$0.34 in-line

    7:13 a.m. May 10, 2022

    - Seeking Alpha

  13. Notable earnings before Tuesday's open

    11:06 a.m. May 9, 2022

    - Seeking Alpha

  14. Loading more headlines...

At a Glance

Gamida Cell Ltd.

116 Huntington Avenue

Boston, Massachusetts 02116

Phone

1 7134006400

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

N/A

Net Income

$-89.79M

Employees

168.00

/news/pressrelease/company/us/gmda

Press Releases on GMDA

  1. MediWound Announces CEO Transition

    7:01 a.m. May 17, 2022

    - GlobeNewswire

  2. 5 Hot Penny Stocks To Watch With Premarket Momentum & News

    8:58 a.m. April 26, 2022

    - Penny Stocks

  3. Loading more headlines...
Link to MarketWatch's Slice.